Tanaka A, Yuasa A, Kamei K, Nagano M, et al. Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan. J Dermatol 2024 Apr 22. doi: 10.1111/1346-8138.17234.
PMID: 38650307